Cureety, has developed and launched a digital telemonitoring platform for the follow-up of
patients with cancer and with chronic diseases, with three main goals:
1. Accompany the patients on their care pathway and improve their lives.
2. Assist caregivers and optimize their work.
3. Bring clinicians and pharma an innovative solution for collecting
high-quality real-world data on the diseases and their treatments.
33 rue de l’amirauté, 22100 Dinan
Targeted indications : breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, supportive care, liver cancer, brain cancer, head & neck cancer, gastrointestinal cancer, gynecological cancer, bone cancer, genitourinary cancer, skin cancer, hematologic cancer, lymphoma, myeloma, leukemia, predictive toxicology.